Renoprotective Effects of DPP-4 Inhibitors

by Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, Ryoko Motonaga, Makito Tanabe
Published 2021-02-01

Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes

by Yoshimi Muta, Tomoko Tanaka, Yuriko Hamaguchi, Nobuya Hamanoue, Ryoko Motonaga, Makito Tanabe, Takashi Nomiyama, Hajime Nawata, Toshihiko Yanase
Published 2019-03-01

Relatively low sex hormone‐binding globulin concentration is a risk factor for hyperuricemia in middle‐aged Japanese men

by Yuya Fujihara, Nobuya Hamanoue, Yuko Akehi, Ryoko Motonaga, Tomoko Tanaka, Chikayo Iwaya, Hiromi Yano, Makito Tanabe, Takashi Nomiyama, Toshihiko Yanase
Published 2020-08-01

Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth.

by Yoko Tsutsumi, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Yuichi Terawaki, Tomoko Tanaka, Kunitaka Murase, Ryoko Motonaga, Makito Tanabe, Toshihiko Yanase
Published 2015-01-01

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice

by Hiroyuki Takahashi, Takashi Nomiyama, Yuichi Terawaki, Takeshi Horikawa, Takako Kawanami, Yuriko Hamaguchi, Tomoko Tanaka, Ryoko Motonaga, Takashi Fukuda, Makito Tanabe, Toshihiko Yanase
Published 2019-07-01

Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression

by Toru Shigeoka, Takashi Nomiyama, Takako Kawanami, Yuriko Hamaguchi, Tsuyoshi Horikawa, Tomoko Tanaka, Shinichiro Irie, Ryoko Motonaga, Nobuya Hamanoue, Makito Tanabe, Kazuki Nabeshima, Masatoshi Tanaka, Toshihiko Yanase, Daiji Kawanami
Published 2020-09-01